HC Advisors LLC Sells 2,604 Shares of HealthEquity, Inc. (NASDAQ:HQY)

HC Advisors LLC lessened its stake in HealthEquity, Inc. (NASDAQ:HQY - Free Report) by 22.4% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 9,030 shares of the company's stock after selling 2,604 shares during the quarter. HealthEquity comprises approximately 0.7% of HC Advisors LLC's investment portfolio, making the stock its 22nd biggest holding. HC Advisors LLC's holdings in HealthEquity were worth $866,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Wasatch Advisors LP raised its position in shares of HealthEquity by 6.6% during the third quarter. Wasatch Advisors LP now owns 7,758,890 shares of the company's stock worth $635,065,000 after acquiring an additional 483,269 shares during the last quarter. Vaughan Nelson Investment Management L.P. increased its position in HealthEquity by 36.7% in the third quarter. Vaughan Nelson Investment Management L.P. now owns 843,423 shares of the company's stock worth $69,034,000 after purchasing an additional 226,563 shares during the period. Barclays PLC raised its holdings in HealthEquity by 209.3% during the 3rd quarter. Barclays PLC now owns 166,492 shares of the company's stock worth $13,628,000 after purchasing an additional 112,667 shares during the last quarter. Thrivent Financial for Lutherans lifted its position in HealthEquity by 33.3% during the 3rd quarter. Thrivent Financial for Lutherans now owns 293,624 shares of the company's stock valued at $24,033,000 after purchasing an additional 73,404 shares during the period. Finally, B. Metzler seel. Sohn & Co. Holding AG bought a new position in shares of HealthEquity in the 3rd quarter valued at about $5,675,000. Institutional investors and hedge funds own 99.55% of the company's stock.

Remove Ads

Analysts Set New Price Targets

A number of equities research analysts recently weighed in on the stock. The Goldman Sachs Group began coverage on shares of HealthEquity in a research note on Friday, November 15th. They set a "neutral" rating and a $108.00 price target for the company. Wells Fargo & Company upped their target price on shares of HealthEquity from $110.00 to $125.00 and gave the company an "overweight" rating in a research report on Wednesday, February 26th. Barrington Research raised their price target on HealthEquity from $105.00 to $120.00 and gave the stock an "outperform" rating in a research report on Monday, December 2nd. Bank of America upped their price objective on HealthEquity from $100.00 to $120.00 and gave the company a "buy" rating in a report on Wednesday, November 13th. Finally, Raymond James increased their target price on HealthEquity from $105.00 to $120.00 and gave the company an "outperform" rating in a research note on Tuesday, February 25th. One research analyst has rated the stock with a hold rating and twelve have issued a buy rating to the stock. According to MarketBeat, HealthEquity has an average rating of "Moderate Buy" and an average price target of $113.54.

HealthEquity Stock Down 4.5 %

Shares of HQY stock traded down $4.94 during trading hours on Monday, hitting $104.82. 924,886 shares of the company were exchanged, compared to its average volume of 733,978. HealthEquity, Inc. has a 52 week low of $65.01 and a 52 week high of $115.59. The company has a current ratio of 3.20, a quick ratio of 3.20 and a debt-to-equity ratio of 0.51. The business has a 50 day moving average of $105.13 and a two-hundred day moving average of $93.67. The company has a market capitalization of $9.08 billion, a PE ratio of 96.17, a PEG ratio of 1.60 and a beta of 0.55.

HealthEquity (NASDAQ:HQY - Get Free Report) last released its quarterly earnings results on Monday, December 9th. The company reported $0.59 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.71 by ($0.12). HealthEquity had a net margin of 8.41% and a return on equity of 9.70%. During the same period last year, the company posted $0.40 earnings per share. Analysts anticipate that HealthEquity, Inc. will post 2.32 earnings per share for the current fiscal year.

Insider Activity at HealthEquity

In other news, Director Robert W. Selander sold 8,250 shares of HealthEquity stock in a transaction that occurred on Monday, December 9th. The stock was sold at an average price of $101.56, for a total transaction of $837,870.00. Following the completion of the transaction, the director now directly owns 66,469 shares in the company, valued at approximately $6,750,591.64. The trade was a 11.04 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, Director Stuart B. Parker sold 25,000 shares of the stock in a transaction on Thursday, December 12th. The shares were sold at an average price of $96.72, for a total value of $2,418,000.00. Following the completion of the sale, the director now owns 19,061 shares in the company, valued at approximately $1,843,579.92. This trade represents a 56.74 % decrease in their position. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 39,000 shares of company stock valued at $3,895,788. Insiders own 2.20% of the company's stock.

HealthEquity Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.